Braverman L E, AvRuskin T, Cullen M J, Vagenakis A G, Ingbar S H
J Clin Invest. 1971 Aug;50(8):1644-9. doi: 10.1172/JCI106653.
Studies of the effect of norethandrolone on the transport and peripheral metabolism of thyroxine were carried out in four patients lacking thyroxine-binding globulin. Before norethandrolone administration, values for serum protein-bound iodine (PBI) were decreased (1.8 +/-0.5 mug/100 ml) and the proportion of free thyroxine increased (0.036 +/-0.008%). As a result, values for the absolute concentration of free thyroxine iodine were at the lower end of the normal range (0.63 +/-0.12 mmug/100 ml). During the control thyroxine-turnover study, the thyroxine distribution space was strikingly increased (18.2 +/-7.9 liters) and the fractional rate of thyroxine turnover moderately increased (17.1 +/-11.3%/day), as compared to the expected mean values for normal subjects. Therefore, calculated values for the daily rate of thyroxine clearance were increased even more, ranging between 255 and 500% of normal values. However, owing to the low PBI in these patients, the daily disposal of thyroxine iodine was similar to that expected in normals on the basis of age and weight. During the administration of norethandrolone, the thyroxine-binding capacity of the thyroxine-binding prealbumin increased strikingly in all patients, values averaging 162% of those found during the control period. This increase was associated with a highly significant increase in PBI (133% of control values) and a small but significant decrease in the proportion of free thyroxine, resulting in no significant change in the absolute concentration of free thyroxine iodine. In all four patients, administration of norethandrolone was associated with a pronounced decrease in the thyroxine distribution space to values which averaged 69% of those found during the control period. Values for the fractional rate of thyroxine turnover increased slightly. As a result, thyroxine-clearance rate decreased in all patients. Owing to the reciprocal changes in clearance rate and PBI, no significant change in total daily thyroxine disposal was observed. The present studies reveal that when the thyroxine-binding prealbumin is increased in patients lacking thyroxine-binding globulin, several indices of peripheral thyroxine transport and metabolism are altered. However, these changes were small, even in the absence of thyroxine-binding globulin. It is suggested, therefore, that the effect of changes in thyroxine-binding prealbumin would be even smaller in individuals in whom thyroxine-binding globulin is present.
对4名缺乏甲状腺素结合球蛋白的患者进行了去甲雄诺龙对甲状腺素转运和外周代谢影响的研究。在给予去甲雄诺龙之前,血清蛋白结合碘(PBI)值降低(1.8±0.5μg/100ml),游离甲状腺素比例增加(0.036±0.008%)。结果,游离甲状腺素碘的绝对浓度值处于正常范围的下限(0.63±0.12μμg/100ml)。在对照甲状腺素周转研究期间,与正常受试者的预期平均值相比,甲状腺素分布空间显著增加(18.2±7.9升),甲状腺素周转分数率适度增加(17.1±11.3%/天)。因此,计算出的甲状腺素清除率每日速率增加得更多,在正常值的255%至500%之间。然而,由于这些患者的PBI较低,基于年龄和体重,甲状腺素碘的每日处置量与正常情况下预期的相似。在给予去甲雄诺龙期间,所有患者中甲状腺素结合前白蛋白的甲状腺素结合能力显著增加,平均值为对照期发现值的162%。这种增加与PBI的高度显著增加(对照值的133%)和游离甲状腺素比例的小幅但显著降低相关,导致游离甲状腺素碘的绝对浓度无显著变化。在所有4名患者中,给予去甲雄诺龙与甲状腺素分布空间显著降低至平均值为对照期发现值的69%相关。甲状腺素周转分数率值略有增加。结果,所有患者的甲状腺素清除率均降低。由于清除率和PBI的相互变化,未观察到每日甲状腺素总处置量的显著变化。目前的研究表明,在缺乏甲状腺素结合球蛋白的患者中,当甲状腺素结合前白蛋白增加时,外周甲状腺素转运和代谢的几个指标会发生改变。然而,即使在没有甲状腺素结合球蛋白的情况下,这些变化也很小。因此,有人提出,在存在甲状腺素结合球蛋白的个体中,甲状腺素结合前白蛋白变化的影响会更小。